CCM Concord Medical Services Holdings Ltd

Overview and Growth

Concord Medical Services Holdings Ltd generated $65.85M of revenue in fiscal 2025, with net loss of $13.27M and an operating cash outflow of $28.86M. Revenue of $65.85M sets the scale for evaluating how effectively sales translated into profit and cash during the year. Revenue was 25.2% above fiscal 2024 revenue of $52.60M, marking a year-over-year increase. Diluted earnings per share were -$0.10, translating the period’s attributable earnings into the amount reported for each diluted share. At period end, total assets were $936.26M, framing the scale of the company’s operating and financing commitments. The revenue-to-assets relationship was 0.07x, showing the sales generated relative to the resources carried on the balance sheet.

Profitability

Gross profit was $3.69M, representing the portion of revenue remaining after the reported cost of revenue and before operating expenses. Gross profit represented 5.6% of revenue, showing how much of the top line remained after direct costs. The reported operating result was an operating loss of $37.39M, reflecting costs that exceeded gross profit. Relative to revenue, the operating deficit measured 56.8%, showing the shortfall after operating costs. After all below-operating-line items, the company recorded a net loss of $13.27M for the fiscal year. Net margin was -20.2%, reflecting a loss equal to 20.2% of reported revenue. The company recognized $867.00K of income tax for the period, completing the transition from pretax income to net income. The net loss equaled 5.0% of period-end equity, showing the deficit relative to book capital. The loss-to-assets relationship was 1.4%, placing the bottom-line deficit against the company’s resource base. Compared with a $42.23M net loss in fiscal 2024, the current loss improved to $13.27M.

Liquidity and Capital Structure

At period end, the $936.26M asset base was financed through $671.70M of liabilities and $264.56M of equity. At period end, current assets of $134.69M compared with current liabilities of $279.48M, defining the company’s short-term resource position. At 0.48x, current liabilities exceeded current assets and placed pressure on the company’s near-term liquidity position. Cash and equivalents totaled $42.58M, identifying the most liquid reported component available within the broader current-asset balance. Measured only with cash and equivalents, coverage of current liabilities was 15.2%, excluding receivables and other current assets. Total debt was $492.85M, establishing the amount of borrowing carried within the company’s capital structure. The debt-to-equity relationship was 1.86x, showing how much debt the company carried for each unit of book equity. Debt represented 52.6% of total assets, placing borrowing in the context of the company’s full resource base. The equity-to-assets relationship was 28.3%, placing book capital against the total resource base. Liabilities represented 71.7% of total assets, quantifying the liability-funded share of the company’s resource base. Cash and equivalents equaled 4.5% of total assets, showing the liquid cash component within the company’s broader resource base. Total assets were 1.6% higher than fiscal 2024 assets of $921.51M, measuring the company’s own balance-sheet change. Reported equity changed 19.4% from $221.63M in fiscal 2024, placing the current capital base higher year over year. Cash and equivalents were 43.7% higher than fiscal 2024 cash of $29.62M, showing the year-over-year change in liquid resources.

Cash Flow and Earnings Quality

Operating activities used $28.86M of cash, resulting in an operating cash outflow for the year. Capital spending of $8.05M added to the period’s operating cash use, reinforcing the overall cash deficit after investment for the year. Negative free cash flow was $36.91M, leaving a cash deficit after capital spending and reducing financial flexibility. Relative to revenue, the post-investment cash deficit represented 56.1%. The cash deficit after capital spending represented 3.9% of the period-end asset base.

Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated Oct 21, 2026.